Genetic and Clinical Factors Associated with Olokizumab Treatment in Russian Patients with Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease and its treatment is an urgent problem of rheumatology. Olokizumab (OKZ) is a new humanized monoclonal antibody targeting IL-6 and is one of the few promising drugs for RA therapy. One-hundred-and-twenty-five DNA samples from Russi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikhaylenko, Dmitry S., Kuznetsova, Ekaterina B., Musatova, Viktoria V., Bure, Irina V., Deryagina, Tatiana A., Alekseeva, Ekaterina A., Tarasov, Vadim V., Zamyatnin, Andrey A., Nemtsova, Marina V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024465/
https://www.ncbi.nlm.nih.gov/pubmed/35455757
http://dx.doi.org/10.3390/jpm12040641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024465/
https://www.ncbi.nlm.nih.gov/pubmed/35455757
http://dx.doi.org/10.3390/jpm12040641

Ejemplares similares